Amunix Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Amunix, based in South San Francisco, California, operates in the biotechnology research sector with a focus on cancer immunotherapy. The company seeks to broaden the usefulness of T cell engagers and cytokines by applying a universal masking strategy that is releasable by tumor-associated proteases, creating conditionally active therapeutics that preferentially act in tumors. This approach is designed to address dose-limiting toxicity that has constrained prior programs in this area. A notable development in 2024 involved a licensing collaboration with Vir Biotechnology. The organization has a history of corporate transactions in the sector, including its acquisition by Sanofi in 2021. The company emphasizes scientific rigor and collaboration as it advances its immuno-oncology pipeline.